|
Palatin Technologies is an American
based biopharmaceutical company engaged in drugs production
by research and studies. Basically it is engaged in the
development of melanocrotin, the hormone based therapeutics
or medicines. Palatin’s strategie s
is to bring out different potent medicinal products to the
market with the collaboration of industrial giants to double
their marketing potential. Palatin technologies also has
great research and development
capability and potentiality. The Palatin is a future star in
biopharmaceutical production and research. It will be one of
the best in world in manufacturing biopharmaceutical
therapeutics. It has experts and scientist teams for
clinical research and development. Research on congestive heart failure, obesity and cachexy is being done by
Palatin Technologies. There have
been research and studies on drugs and its action towards
these diseases. There are different medical projects in the
pipeline of the Palatin Technologies. During August 2004, Palatin made a
strategic alliance with one of the manufacturing and
marketing giant, King Pharmaceuticals to bring out a drug
called Bremelanotide and commercialize it to great extend in
the market.
Palatin Technologies after long
speculation and research work came out with a wonderful and
potent drug called Bremelanotide to combat male erectile
dysfunction (ED) and female sexual dysfunction (FSD). This
drug, Bremelanotide has made positive impact on the patients
and it will create and revolution among the patients.
Palatin Technologies has created the
drug, Bremelanotide, which is based on hormone called
melanocrotin, it directly acts in central nervous system and
works effectively and positively to create sexual desire and
genital arousal in male and female. Palatin Technologies is first one to
bring Bremelanotide, nasal spray formulation to the market,
which is safe and easy to use.
|
|
